Related references
Note: Only part of the references are listed.Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate
Dennis J. Nieuwkamp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
Thorsten Rosenkranz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effects of dimethyl fumarate on lymphocyte subsets
Regina Berkovich et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Dimethyl fumarate associated lymphopenia in clinical practice
Erin E. Longbrake et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod
Zi-Ye Song et al.
PLOS ONE (2015)
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Collin M. Spencer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Daclizumab (anti-CD25) in multiple sclerosis
Nikolai Pfender et al.
EXPERIMENTAL NEUROLOGY (2014)
The Plasmacytoid Dendritic Cell as the Swiss Army Knife of the Immune System: Molecular Regulation of Its Multifaceted Functions
Julien J. Karrich et al.
JOURNAL OF IMMUNOLOGY (2014)
Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: Case report and review of the literature
Alex McBath et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2014)
CD4+T-cell depletion in HIV infection: mechanisms of immunological failure
Afam A. Okoye et al.
IMMUNOLOGICAL REVIEWS (2013)
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis
Domenico Plantone et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia
Manuel Delgado-Alvarado et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
Nicholas Schwab et al.
NEUROLOGY (2013)
PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
Bob W. van Oosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Multiple sclerosis
Alyssa Nylander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
CD8+ T Cells Primed in the Periphery Provide Time-Bound Immune-Surveillance to the Central Nervous System
Kevin G. Young et al.
JOURNAL OF IMMUNOLOGY (2011)
Autoimmune T cell responses in the central nervous system
Joan Goverman
NATURE REVIEWS IMMUNOLOGY (2009)
Plasmacytoid dendritic cells in multiple sclerosis:: Intracerebral recruitment and impaired maturation in response to interferon-β
Roberto Lande et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
Phenotypic and functional features of human Th17 cells
Francesco Annunziato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis
O. Li et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Development, trafficking, and function of memory T-cell subsets
Leo Lefrancois
IMMUNOLOGICAL REVIEWS (2006)
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS
D Giunti et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)